Early research (Phase 1)Ended earlyNCT00736528What this trial is testingA Phase I, Multiple Dose Study of PF-04447943 in Healthy Elderly VolunteersWho this might be right forHealthyElderly Pfizer 10
Early research (Phase 1)Study completedNCT05131971What this trial is testingEvaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics (PD) of GSK3888130B in Healthy ParticipantsWho this might be right forMultiple SclerosisColitis, Ulcerative GlaxoSmithKline 54
Early research (Phase 1)Study completedNCT02264093What this trial is testingEffects on the Airway Lumen of Talsaclidine in Combination With Propranolol in Comparison to the Effects of the Monosubstances in Healthy Elderly Male VolunteersWho this might be right forHealthy Boehringer Ingelheim 12
Early research (Phase 1)Study completedNCT03022799What this trial is testingPhase I, KM-819 in Healthy Subjects for Parkinson's DiseaseWho this might be right forParkinson's Disease Kainos Medicine Inc. 88
Early research (Phase 1)Study completedNCT02560077What this trial is testingEffect of Cashew Apple Juice on the Physiological and Psychological Fitness in the Middle Aged and Elderly VolunteersWho this might be right forHealthy Khon Kaen University 45
Early research (Phase 1)Study completedNCT03561181What this trial is testingSafety Study of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Healthy Volunteers Aged Above 3 MonthsWho this might be right forDysenteryDysentery, Bacillary Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 180
Early research (Phase 1)Study completedNCT02243657What this trial is testingAssess the Safety, Tolerability, and Effects in and on the Body of Healthy Young and Elderly Male and Female Subjects of Ascending Multiple Oral Doses of ASP3652Who this might be right forHealthy SubjectsPharmacokinetics of ASP3652Pharmacodynamics of ASP3652 Astellas Pharma Europe B.V. 101
Large-scale testing (Phase 3)Study completedNCT03135834What this trial is testingA Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to <26 Years of Age.Who this might be right forMeningococcal Vaccine Pfizer 1,610
Large-scale testing (Phase 3)Study completedNCT03525119What this trial is testingImmunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Co-administered With an Hepatitis A Virus VaccineWho this might be right forHealthy Volunteers Takeda 900
Early research (Phase 1)Study completedNCT02954263What this trial is testingMultiple Ascending Dose Study of TD-1439 in Healthy Adult and Elderly SubjectsWho this might be right forHealthy Adults, Elderly Subjects Theravance Biopharma 40
Early research (Phase 1)Study completedNCT01611311What this trial is testingSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 409306Who this might be right forHealthy Boehringer Ingelheim 40
Post-approval studies (Phase 4)Study completedNCT01591837What this trial is testingAssess the Immunogenicity and Safety of CSL's 2012/2013 Formulation of Enzira® Vaccine in Healthy VolunteersWho this might be right forInfluenza, Human Seqirus 120
Not applicableStudy completedNCT00725166What this trial is testingHuman Muscle Gene Expression Profiles in Young and Old MenWho this might be right forElderlySarcopenia Centre Hospitalier Universitaire de Saint Etienne 41
Not applicableStudy completedNCT02822612What this trial is testingThe EASE Study - Human Factor and Usability Testing of a Binocular OCT SystemWho this might be right forGlaucomaRetinal DiseaseStrabismus+1 more University College, London 60
Early research (Phase 1)Study completedNCT01051700What this trial is testingA Safety Study in Healthy Volunteers to Evaluate Safety, How Fast the Drug is Absorbed, and the Side Effects of the Drug in HumansWho this might be right forMacular Degeneration GlaxoSmithKline 72
Early research (Phase 1)Study completedNCT06237296What this trial is testingStudy of the Safety and Immune Response of an Investigational mRNA Vaccine for the Prevention of Respiratory Syncytial Virus and/or Human Metapneumovirus in Participants Aged 18 to 49 Years and 60 Years and OlderWho this might be right forRespiratory Syncytial Virus InfectionHealthy VolunteersMetapneumovirus Infection Sanofi Pasteur, a Sanofi Company 558
Testing effectiveness (Phase 2)Study completedNCT00427908What this trial is testingStudy in Children to Evaluate Non-Inferiority and Persistence up to 5 Years of GSK Bio Meningococcal Vaccine 134612Who this might be right forInfections, Meningococcal GlaxoSmithKline 613
Early research (Phase 1)Study completedNCT03316521What this trial is testingFirst-In-Human Clinical Study of the C3 Complement Inhibitor AMY- 101 in Healthy Male VolunteersWho this might be right forComplement Mediated Diseases Amyndas Pharmaceuticals S.A. 50
Not applicableStudy completedNCT00029120What this trial is testingEvaluation of Age- and Alzheimer's Disease-Related Memory DisorderWho this might be right forAlzheimer DiseaseDementiaMemory Disorder+1 more National Institute of Mental Health (NIMH) 450
Early research (Phase 1)Study completedNCT03594890What this trial is testingSafety and Immune Response of Increasing Doses of OVX836 After Intramuscular or Intranasal Administrations in Healthy SubjectsWho this might be right forInfluenza Osivax 72